FDAnews Drug Daily Bulletin

Particulates Force Hospira to Recall Fourth Injectable This Year

Feb. 2, 2017

Hospira voluntarily recalled one lot of an injectable product following the discovery of particulate matter in vials — the fourth such recall the company has had to issue in the past year.

The company is recalling 100 mL vials of vancomycin hydrochloride carrying the lot number 591053A, distributed from August through September 2016 to U.S. hospital and retail pharmacies. Hospira plans to notify direct customers via a recall letter, and is arranging for the product to be collected for disposal.

Hospira, a Pfizer company, has been plagued with injectable recalls and customer complaints of particulate matter. It recalled single lots of sodium bicarbonate in March 2016, magnesium sulfate the following April, and bupivacaine hydrochloride later that August.

View today's stories